Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC
RecruitingOBSERVATIONAL
Enrollment
250
Participants
Timeline
Start Date
June 15, 2025
Primary Completion Date
July 1, 2028
Study Completion Date
July 1, 2030
Conditions
Colorectal Cancer
Trial Locations (1)
200025
RECRUITING
Ruijin hospital Shanghai Jiaotong University, School of Medicine, Shanghai
All Listed Sponsors
lead
Shanghai Minimally Invasive Surgery Center
OTHER
NCT07068529 - Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC | Biotech Hunter | Biotech Hunter